A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Clinical trial NCT03547115 · TERMINATED

Trial details

NCT number: NCT03547115
Sponsor: MEI Pharma, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)Small Lymphocytic Lymphoma (SLL)Chronic Lymphocytic Leukemia (CLL)Diffuse Large B-cell Lymphoma (DLBCL)Acute Myeloid Leukemia (AML)

Start date: 2018-05-31
Primary completion: 2024-07-24
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.